AFP and neoplasm: Importantly, in the HCC patients with small tumor sizes (<5 cm), our triplex miRNA and Mir@AFP panels also showed a greater diagnostic performance in distinguishing HCC from the other HBV-related liver diseases, especially from patients with LC.